Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

START Trial Shows Benefits of Early Treatment, Supports ART For All

START Trial Shows Benefits of Early Treatment, Supports ART For All

, by Liz Highleyman

Complete results from the START trial leave no room for doubt about benefits of early HIV treatment—and will influence development of world’s ART guidelines. Read More

Early Antiretroviral Therapy: Progress in HIV Cure Research

Early Antiretroviral Therapy: Progress in HIV Cure Research

, by Liz Highleyman

Early delivery of antiretroviral therapy (ART) soon after HIV infection holds promise as a way to reduce the size of the viral reservoir. What does this mean for HIV cure research? Read More

Predicting HIV Rebound: Progress in HIV Cure Research

Predicting HIV Rebound: Progress in HIV Cure Research

, by Liz Highleyman

When HIV treatment is stopped, viral load rebounds. New research that can predict viral load rebound might prove useful for researchers working on an HIV cure. Read More

Blocking PD-1: Progress in HIV Cure Research

Blocking PD-1: Progress in HIV Cure Research

, by Liz Highleyman

Blocking a signaling molecule called PD-1 on immune cells is one way researchers are reducing HIV viral load and improving immune system function in monkeys. Find out what role this strategy might play in the search for an HIV cure. Read More

Timothy Ray Brown, the Berlin Patient, Accepts Award

Timothy Ray Brown, the Berlin Patient, Accepts Award

, by Liz Highleyman

The Berlin Patient recently accepted an award at a San Francisco HIV cure symposium. Find out why he receives special recognition as researchers use his case to learn more about how to cure HIV. Read More